 Arturo Barbachano-Guerrero
Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dengue Virus | 6 | 2025 | 53 | 1.210 |
Why?
| | Dengue | 5 | 2025 | 83 | 1.170 |
Why?
| | Dog Diseases | 2 | 2023 | 65 | 0.920 |
Why?
| | Influenza in Birds | 1 | 2023 | 5 | 0.800 |
Why?
| | Influenza A Virus, H3N2 Subtype | 1 | 2023 | 46 | 0.780 |
Why?
| | Viral Nonstructural Proteins | 1 | 2020 | 67 | 0.620 |
Why?
| | Capillary Permeability | 1 | 2020 | 148 | 0.610 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2020 | 281 | 0.590 |
Why?
| | Bird Diseases | 1 | 2018 | 18 | 0.580 |
Why?
| | West Nile virus | 1 | 2018 | 42 | 0.570 |
Why?
| | West Nile Fever | 1 | 2018 | 53 | 0.560 |
Why?
| | Endothelial Cells | 1 | 2020 | 813 | 0.430 |
Why?
| | Carrier State | 2 | 2021 | 71 | 0.330 |
Why?
| | Birds | 2 | 2023 | 100 | 0.330 |
Why?
| | Sarcoma, Kaposi | 3 | 2021 | 80 | 0.320 |
Why?
| | Mammals | 2 | 2023 | 286 | 0.290 |
Why?
| | Pan troglodytes | 2 | 2025 | 65 | 0.280 |
Why?
| | Mexico | 5 | 2020 | 229 | 0.270 |
Why?
| | Chikungunya Fever | 2 | 2018 | 80 | 0.260 |
Why?
| | Herpesvirus 8, Human | 2 | 2018 | 66 | 0.250 |
Why?
| | Reverse Genetics | 1 | 2025 | 7 | 0.230 |
Why?
| | Gorilla gorilla | 1 | 2025 | 18 | 0.230 |
Why?
| | CD4 Antigens | 1 | 2025 | 141 | 0.220 |
Why?
| | Receptor, Interferon alpha-beta | 1 | 2024 | 35 | 0.220 |
Why?
| | Dogs | 2 | 2023 | 426 | 0.220 |
Why?
| | Simian Immunodeficiency Virus | 1 | 2025 | 92 | 0.220 |
Why?
| | Simian Acquired Immunodeficiency Syndrome | 1 | 2025 | 92 | 0.220 |
Why?
| | DNA Transposable Elements | 1 | 2024 | 120 | 0.210 |
Why?
| | Virology | 1 | 2024 | 36 | 0.210 |
Why?
| | Orthomyxoviridae | 1 | 2024 | 39 | 0.210 |
Why?
| | Alouatta | 2 | 2020 | 3 | 0.200 |
Why?
| | Exons | 1 | 2024 | 352 | 0.200 |
Why?
| | Alternative Splicing | 1 | 2024 | 232 | 0.190 |
Why?
| | Hemorrhagic Fevers, Viral | 1 | 2022 | 16 | 0.190 |
Why?
| | Saliva | 2 | 2021 | 245 | 0.190 |
Why?
| | Arterivirus | 1 | 2022 | 18 | 0.190 |
Why?
| | Orthomyxoviridae Infections | 1 | 2023 | 66 | 0.190 |
Why?
| | Influenza A virus | 1 | 2023 | 110 | 0.190 |
Why?
| | Coccidiosis | 1 | 2021 | 1 | 0.180 |
Why?
| | Eucoccidiida | 1 | 2021 | 1 | 0.180 |
Why?
| | Human Umbilical Vein Endothelial Cells | 2 | 2020 | 108 | 0.180 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2024 | 265 | 0.170 |
Why?
| | Animals, Domestic | 1 | 2020 | 16 | 0.170 |
Why?
| | Animals | 12 | 2025 | 37579 | 0.170 |
Why?
| | Drug Resistance, Bacterial | 1 | 2020 | 189 | 0.150 |
Why?
| | Immunoglobulin E | 1 | 2021 | 331 | 0.150 |
Why?
| | Signal Transduction | 2 | 2024 | 5148 | 0.150 |
Why?
| | Cell Line | 2 | 2025 | 2879 | 0.140 |
Why?
| | Models, Biological | 2 | 2024 | 1822 | 0.140 |
Why?
| | RNA, Viral | 2 | 2021 | 691 | 0.140 |
Why?
| | Chagas Disease | 1 | 2018 | 44 | 0.140 |
Why?
| | Parasite Egg Count | 1 | 2017 | 5 | 0.140 |
Why?
| | Parasite Load | 1 | 2017 | 10 | 0.140 |
Why?
| | Intestinal Diseases, Parasitic | 1 | 2017 | 12 | 0.140 |
Why?
| | Antigens, Viral | 1 | 2018 | 178 | 0.140 |
Why?
| | HIV-1 | 1 | 2024 | 880 | 0.140 |
Why?
| | Pharynx | 1 | 2018 | 61 | 0.140 |
Why?
| | Nasal Cavity | 1 | 2018 | 61 | 0.130 |
Why?
| | Encephalitis Virus, Venezuelan Equine | 1 | 2017 | 6 | 0.130 |
Why?
| | Encephalitis Virus, Eastern Equine | 1 | 2017 | 5 | 0.130 |
Why?
| | Phylogeny | 2 | 2018 | 1005 | 0.130 |
Why?
| | Herpesviridae Infections | 1 | 2018 | 148 | 0.130 |
Why?
| | Mast Cells | 1 | 2018 | 153 | 0.130 |
Why?
| | Virus Replication | 3 | 2025 | 531 | 0.130 |
Why?
| | Zika Virus Infection | 1 | 2018 | 165 | 0.120 |
Why?
| | Escherichia coli | 1 | 2020 | 835 | 0.120 |
Why?
| | Macrophages | 1 | 2024 | 1559 | 0.120 |
Why?
| | Viruses | 1 | 2018 | 163 | 0.120 |
Why?
| | Gastrointestinal Tract | 1 | 2017 | 197 | 0.110 |
Why?
| | Virus Activation | 1 | 2015 | 86 | 0.110 |
Why?
| | Feces | 1 | 2017 | 493 | 0.110 |
Why?
| | STAT3 Transcription Factor | 1 | 2015 | 211 | 0.100 |
Why?
| | Genotype | 1 | 2018 | 1862 | 0.100 |
Why?
| | Endothelium, Vascular | 1 | 2020 | 949 | 0.100 |
Why?
| | Repressor Proteins | 1 | 2015 | 428 | 0.090 |
Why?
| | Pneumonia | 1 | 2018 | 656 | 0.090 |
Why?
| | Culicidae | 2 | 2025 | 35 | 0.090 |
Why?
| | Bacteria | 1 | 2018 | 874 | 0.090 |
Why?
| | Humans | 15 | 2025 | 140898 | 0.080 |
Why?
| | Ecuador | 2 | 2018 | 10 | 0.070 |
Why?
| | Specimen Handling | 2 | 2021 | 179 | 0.070 |
Why?
| | Chikungunya virus | 2 | 2018 | 82 | 0.070 |
Why?
| | HIV Infections | 1 | 2021 | 2967 | 0.060 |
Why?
| | Asthma | 1 | 2018 | 1919 | 0.060 |
Why?
| | Aedes | 1 | 2025 | 64 | 0.050 |
Why?
| | Viral Tropism | 1 | 2024 | 34 | 0.050 |
Why?
| | Genome, Viral | 1 | 2025 | 223 | 0.050 |
Why?
| | Interferons | 1 | 2024 | 195 | 0.050 |
Why?
| | Protein Isoforms | 1 | 2024 | 398 | 0.050 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2024 | 103 | 0.050 |
Why?
| | Macaca | 1 | 2022 | 65 | 0.050 |
Why?
| | Virus Internalization | 1 | 2022 | 64 | 0.050 |
Why?
| | HEK293 Cells | 1 | 2024 | 737 | 0.050 |
Why?
| | Primates | 1 | 2022 | 133 | 0.040 |
Why?
| | RNA, Ribosomal, 18S | 1 | 2021 | 27 | 0.040 |
Why?
| | RNA, Protozoan | 1 | 2021 | 60 | 0.040 |
Why?
| | Phylogeography | 1 | 2021 | 57 | 0.040 |
Why?
| | Nucleic Acid Amplification Techniques | 1 | 2021 | 36 | 0.040 |
Why?
| | Asymptomatic Infections | 1 | 2021 | 36 | 0.040 |
Why?
| | Rainforest | 1 | 2020 | 7 | 0.040 |
Why?
| | Gene Flow | 1 | 2021 | 83 | 0.040 |
Why?
| | Uganda | 1 | 2021 | 86 | 0.040 |
Why?
| | Monocytes | 1 | 2024 | 578 | 0.040 |
Why?
| | Interleukin-33 | 1 | 2021 | 50 | 0.040 |
Why?
| | Virion | 1 | 2021 | 113 | 0.040 |
Why?
| | Retrospective Studies | 1 | 2018 | 16315 | 0.040 |
Why?
| | CD4 Lymphocyte Count | 1 | 2021 | 273 | 0.040 |
Why?
| | Molecular Diagnostic Techniques | 1 | 2021 | 102 | 0.040 |
Why?
| | Biomarkers | 2 | 2024 | 4175 | 0.040 |
Why?
| | Flow Cytometry | 1 | 2024 | 1195 | 0.040 |
Why?
| | Haplotypes | 1 | 2021 | 499 | 0.040 |
Why?
| | Hospitalization | 2 | 2021 | 2261 | 0.040 |
Why?
| | Viral Load | 1 | 2021 | 498 | 0.040 |
Why?
| | Methylhistamines | 1 | 2018 | 1 | 0.040 |
Why?
| | Tryptases | 1 | 2018 | 13 | 0.040 |
Why?
| | Trypanosoma cruzi | 1 | 2018 | 40 | 0.040 |
Why?
| | Immunity, Innate | 1 | 2024 | 852 | 0.040 |
Why?
| | Fibroblasts | 1 | 2024 | 1017 | 0.040 |
Why?
| | Universities | 1 | 2021 | 449 | 0.040 |
Why?
| | Zinc Sulfate | 1 | 2017 | 8 | 0.030 |
Why?
| | Nematoda | 1 | 2017 | 11 | 0.030 |
Why?
| | Male | 6 | 2021 | 69893 | 0.030 |
Why?
| | Cities | 1 | 2018 | 134 | 0.030 |
Why?
| | Formaldehyde | 1 | 2017 | 65 | 0.030 |
Why?
| | Child, Hospitalized | 1 | 2018 | 53 | 0.030 |
Why?
| | Disease Vectors | 1 | 2017 | 16 | 0.030 |
Why?
| | Coinfection | 1 | 2018 | 131 | 0.030 |
Why?
| | Arboviruses | 1 | 2017 | 14 | 0.030 |
Why?
| | Sucrose | 1 | 2017 | 111 | 0.030 |
Why?
| | Zika Virus | 1 | 2018 | 128 | 0.030 |
Why?
| | Trematode Infections | 1 | 2017 | 49 | 0.030 |
Why?
| | Insect Vectors | 1 | 2017 | 39 | 0.030 |
Why?
| | Female | 6 | 2021 | 75540 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2018 | 344 | 0.030 |
Why?
| | Metagenome | 1 | 2018 | 151 | 0.030 |
Why?
| | Whole Genome Sequencing | 1 | 2018 | 169 | 0.030 |
Why?
| | Zoonoses | 1 | 2017 | 38 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2024 | 1761 | 0.030 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2018 | 985 | 0.030 |
Why?
| | Disease Susceptibility | 1 | 2018 | 352 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 851 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2024 | 1999 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2021 | 1968 | 0.030 |
Why?
| | Horses | 1 | 2017 | 200 | 0.030 |
Why?
| | Tyrphostins | 1 | 2015 | 18 | 0.030 |
Why?
| | Adult | 4 | 2021 | 39134 | 0.030 |
Why?
| | Tripartite Motif-Containing Protein 28 | 1 | 2015 | 18 | 0.030 |
Why?
| | Seasons | 1 | 2018 | 542 | 0.030 |
Why?
| | Virus Latency | 1 | 2015 | 80 | 0.030 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2015 | 99 | 0.030 |
Why?
| | Urban Renewal | 1 | 2014 | 5 | 0.030 |
Why?
| | Population Surveillance | 1 | 2018 | 479 | 0.030 |
Why?
| | Molecular Typing | 1 | 2014 | 20 | 0.030 |
Why?
| | Aged | 3 | 2018 | 24666 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2018 | 1726 | 0.030 |
Why?
| | RNA Interference | 1 | 2015 | 468 | 0.030 |
Why?
| | Infant | 2 | 2018 | 9790 | 0.030 |
Why?
| | Chiroptera | 1 | 2014 | 64 | 0.030 |
Why?
| | Skin | 1 | 2018 | 764 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2015 | 624 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2021 | 3578 | 0.020 |
Why?
| | Child, Preschool | 2 | 2018 | 11462 | 0.020 |
Why?
| | Mass Screening | 1 | 2021 | 1300 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2898 | 0.020 |
Why?
| | Spleen | 1 | 2014 | 522 | 0.020 |
Why?
| | Middle Aged | 3 | 2018 | 34487 | 0.020 |
Why?
| | Pyridines | 1 | 2015 | 553 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2014 | 1052 | 0.020 |
Why?
| | Prevalence | 1 | 2018 | 2780 | 0.020 |
Why?
| | Colorado | 1 | 2021 | 4597 | 0.020 |
Why?
| | Cytokines | 1 | 2018 | 2092 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2021 | 5645 | 0.020 |
Why?
| | Adolescent | 2 | 2018 | 22027 | 0.020 |
Why?
| | Child | 2 | 2018 | 22313 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2015 | 3487 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2018 | 7899 | 0.010 |
Why?
| | Young Adult | 1 | 2018 | 13646 | 0.010 |
Why?
|
|
Barbachano-Guerrero's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|